NEW DELHI — India is struggling to export its surplus of Covid-19 vaccines as logistical hurdles delay their use in many countries despite low levels of inoculation, vaccine producer the Serum Institute of India (SII) and a government official said on Tuesday (Dec 14). The SII, the world's biggest vaccine maker that produces the AstraZeneca, Novavax and Sputnik Covid-19 shots,...